Contact: Nick Day | (612) 396-2908 | [email protected]
***MEDIA ADVISORY FOR WEDNESDAY, AUGUST 18 AT 11:30 AM PT // 2:30 PM ET ***
TODAY: Policy Experts and Researchers, Providers, and Advocates Join Protect Our Care California to Present New Study Confirming H.R. 3 Will Not Harm Pharma Innovation
New research confirms House Democrats’ Rx drug legislation will not impact pharmaceutical innovation
San Diego, CA — On Wednesday, August 18 at 11:30 AM PT, Tim Lash, Chief Strategy Officer of West Health, a family of nonpartisan, nonprofit organizations dedicated to lowering healthcare costs to enable successful aging, and Dr. Jennifer Poast, Director of the Research Division of San Ysidro Health, will join Protect Our Care California to discuss new research confirming that the Lower Drug Costs Now Act (H.R. 3) — Democrats’ legislation to lower prescription drug costs — will not negatively affect innovation in the pharmaceutical industry.
In April, House Democrats re-introduced the Lower Drug Costs Now Act (H.R. 3), bold legislation to give Medicare the power to negotiate for lower drug costs — the single most effective measure to bring down drug prices. The Lower Drug Costs Now Act would save taxpayers $500 billion and reduce the prices for the most expensive medications by as much as 55 percent — saving patients an estimated $158 billion. Now Democrats are fighting to include the key provisions of H.R. 3 in upcoming budget reconciliation legislation.
Last week, Protect Our Care launched its nationwide “Lower Costs, Better Care” bus tour to highlight the work of Democratic lawmakers who are leading the charge to advance American health care and hold Republicans accountable for continuing to reject measures to improve care and lower costs for Americans. Care Force One will make stops in San Diego and Anaheim on Thursday, September 2.
Protect Our Care California
Tim Lash, Chief Strategy Officer of West Health
Jennifer Poast, D.O., M.A., Core Faculty & Director of Research at San Ysidro Health
Annemarie Gibson, a mother of two children with Type 1 diabetes
WHAT: Virtual Press Conference
WHEN: Wednesday, August 18 at 11:30 AM PT // 2:30 PM ET
WHERE: Register to join the Zoom event (Registration required)